CARLY DUNN: Open Payments
NPI 1881284271 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 36 payments from 13 companies in 2025. Trend: 2023 $551 · 2024 $1,176 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $262 |
| Sumitomo Pharma America, Inc. | 4 | $110 |
| PFIZER INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $41 |
| Lilly USA, LLC | 2 | $39 |
| Madrigal Pharmaceuticals | 2 | $36 |
| Amgen Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $23 |
| QOL Medical, LLC | 1 | $22 |
Products named: Wegovy, GEMTESA, Ozempic, SHINGRIX, REZDIFFRA, OTEZLA, Rybelsus, ELIQUIS.
Industry payments across NC — which companies pay providers there.
